chemotherapy-associated neutropenia
Showing 1 - 25 of >10,000
Non Small Cell Lung Cancer Trial in China (Efgbemalenograstim alfa)
Not yet recruiting
- Non Small Cell Lung Cancer
- Efgbemalenograstim alfa
-
Zhengzhou, Henan, China
- +9 more
Nov 16, 2023
Neutropenia Trial in Cairo (Lithium Carbonate)
Completed
- Neutropenia
- Lithium Carbonate
-
Cairo, Non-US/Non-Canadian, EgyptAl-Azhar University
Oct 20, 2022
Breast Tumors Trial in Busan (Eflapegrastim)
Not yet recruiting
- Breast Neoplasms
-
Busan, Korea, Republic ofGood Gang-An Hospital
Jul 9, 2023
Patient Preference BetweenPrefilled Syringe orPrefilled Pen
Recruiting
- Patient Preference
- +2 more
- PELGRAZ prefilled syringe or PELGRAZ prefilled pen
-
Levallois-Perret, Ile-de-France, FranceInstitut Rafael
Jun 19, 2023
Pediatric Cancer, Neutropenia, Lenograstim Trial in Taoyuan (G-CSF administration (bolus injection versus intravenous infusion))
Recruiting
- Pediatric Cancer
- +4 more
- G-CSF administration (bolus injection versus intravenous infusion)
-
Taoyuan, ROC, TaiwanChang Gung Children Hospital
Nov 21, 2023
Febrile Neutropenia, Solid Tumor, Hematologic Tumors Trial in Clamart, Le Kremlin-Bicêtre (NEUTROSIS)
Completed
- Febrile Neutropenia
- +2 more
- NEUTROSIS
-
Clamart, France
- +2 more
May 2, 2022
Severe Neutropenia After HIPEC Using Mitomycin-C
Recruiting
- Colorectal Cancer Metastatic
- +3 more
- Intraoperative blood and peritoneal fluid samplings during HIPEC
-
Seoul, Korea, Republic ofDivision of Colon and Rectal Surgery, Department of Surgery, Gan
Aug 21, 2022
Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed
Completed
- Ovarian Neoplasm
- +4 more
- (no location specified)
Aug 22, 2022
Breast Tumors, Chemo-induced Peripheral Neuropathy Trial in Changhua (Transcutaneous Electrical Nerve Stimulation)
Not yet recruiting
- Breast Neoplasms
- Chemotherapy-induced Peripheral Neuropathy
- Transcutaneous Electrical Nerve Stimulation
-
Changhua, TaiwanChanghua Christian Hospital
Jun 13, 2023
Learn About Dangers Linked to Myelosuppression in Breast Cancer
Not yet recruiting
- Breast Cancer
- (no location specified)
Jan 24, 2023
Acute Myeloid Leukemia Trial in Cologne, Mainz, Munich (APX001 with Standard of Care anti-fungal agent)
Completed
- Acute Myeloid Leukemia
- APX001 with Standard of Care anti-fungal agent
-
Cologne, Germany
- +2 more
Jun 6, 2022
Breast Cancer Trial (Probiotic, Placebo)
Not yet recruiting
- Breast Cancer
- Probiotic
- Placebo
- (no location specified)
Sep 14, 2023
The Oral Cavity as a Source of Febrile Neutropenia
Completed
- Febrile Neutropenia
- +3 more
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Center
Nov 26, 2021
Cancer, Chemotherapeutic Agent Toxicity Trial in Santiago (Contigo Application)
Not yet recruiting
- Cancer
- Chemotherapeutic Agent Toxicity
- Contigo Application
-
Santiago, ChileComplejo Asistencial Dr. Sotero del Río
Oct 10, 2023
Cancer-related Fatigue, Neutropenia, Malignant Trial in Taiwan (Astragalus polysaccharides 500 mg, Placebo, EC Chemotherapy)
Completed
- Cancer-related Fatigue
- Neutropenia, Malignant
- Astragalus polysaccharides 500 mg
- +2 more
-
Kaohsiung City, Taiwan
- +4 more
Jun 13, 2022
Pediatric Cancer Trial in Guangzhou (pegylated recombinant human granulocyte-colony stimulating factor)
Recruiting
- Pediatric Cancer
- pegylated recombinant human granulocyte-colony stimulating factor
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center,
Aug 27, 2021
Breast Cancer, Lymphoma Trial in Oklahoma City (PARASYM TENS unit, PARASYM TENS unit (Placebo))
Not yet recruiting
- Breast Cancer
- Lymphoma
- PARASYM TENS unit
- PARASYM TENS unit (Placebo)
-
Oklahoma City, OklahomaStephenson Cancer Center
Jun 26, 2023
Neutropenia Trial in Beijing (Pegfilgrastim)
Completed
- Neutropenia
-
Beijing, Beijing, ChinaDepartment of Medical Oncology
Mar 12, 2022
Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone
Withdrawn
- Drug/Agent Toxicity by Tissue/Organ
- +3 more
- amifostine trihydrate
- +2 more
-
Chicago, Illinois
- +3 more
Jan 31, 2023
Study to Evaluate the Usability of PointCheck
Active, not recruiting
- Neoplasms
- Chemotherapy-induced Neutropenia
- PointCheck
-
Barcelona, Spain
- +1 more
Oct 20, 2021
Colorectal Cancer Trial (bevacizumab, filgrastim, fluorouracil)
Completed
- Colorectal Cancer
- bevacizumab
- +4 more
- (no location specified)
Mar 27, 2020
Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy
Recruiting
- Neuropathy Associated With Dysproteinaemias
- no intervention
-
Tekirdağ, TurkeyTekirdag Namik Kemal University
Nov 15, 2022
Barriers Associated With Timely Adjuvant Chemotherapy
Active, not recruiting
- Invasive Breast Carcinoma
- Interview
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 25, 2022
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell
Completed
- AIDS-related Diffuse Large Cell Lymphoma
- +8 more
- cyclophosphamide
- +7 more
-
Eldoret, Kenya
- +1 more
Sep 12, 2022
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Jul 25, 2023